NCCN Updates NHL Guidelines
Two recent FDA approvals have prompted the National Comprehensive Cancer Network to update the NCCN Clinical Practice Guidelines in Oncology™ for Non-Hodgkin’s Lymphomas treatment options for selected people with two types of non-Hodgkin’s Lymphomas.
What Happens After Treatment for Non-Hodgkin Lymphoma?
Completing treatment can be both stressful and exciting. You will be relieved to finish treatment, yet it is hard not to worry about cancer coming back. This is a very common concern among those who have had cancer.
Coping with Blood Cancers
Cure rates and remission periods for adults with leukemia, lymphoma, myeloma, myelodysplastic syndromes, and other blood cancers are greatly improved because of new drugs, new uses for existing drugs, and improvements in radiation therapy and stem cell transplantation techniques. Research to improve health outcomes for more people with blood cancers is ongoing. Physicians are working to tailor therapies to decrease side effects, as well as long-term and late effects.
Hodgkin Lymphoma Survivors Have Increased Risk of Stroke and Transient Ischemic Attack
People treated for Hodgkin lymphoma with radiation therapy have a substantially higher risk of stroke, according to a new study published in the Journal of the National Cancer Institute.
Leukemia & Lymphoma Society Fighting Blood Cancers
by Peter West
More than 138,000 Americans will be diagnosed with leukemia, lymphoma, and myeloma this year. For many, a trusted source of information and support will be The Leukemia & Lymphoma Society.
Helping Survivors Thrive after Marrow and Cord Blood Transplants
by Elizabeth A. Murphy, EdD, RN
Advances in transplant science have improved outcomes and have made transplant a viable treatment option for more people and a wider range of diseases.
Questions to Ask Before Beginning Non-Hodgkin Lymphoma Treatment
You may want to ask your doctor these questions before you begin treatment for Non-Hodgkin Lymphoma.
Understanding the Side Effects of Treatment for Hodgkin and Non-Hodgkin Lymphomas
The goal of treatment for Hodgkin lymphoma is to cure the patient. Chemotherapy or a combination of chemotherapy and radiation can result in cures. Over 75 percent of all people diagnosed with Hodgkin lymphoma can be cured by current treatment approaches. The goal of treatment for non-Hodgkin lymphoma is to destroy as many malignant cells as possible and to induce a complete remission, that is, to eliminate all evidence of disease. In some cases in which this goal is accomplished, a cure may be achieved.